Print Page Print Page  |  E-mail Page E-mail Page  |  RSS RSS  |  E-mail Alerts E-mail Alerts  |  Tearsheet Tearsheet
  Home > Investor Relations > SEC Filings
 Investor Home
 Corporate Information
 Stock Information
 Press Releases
 Financial Information
 Events
 Contact Us

SEC Filings

Form SC 13E3/A
IKANG HEALTHCARE GROUP, INC. filed this Form SC 13E3/A on 07/16/2018
Document Outline
Entire Document (2252.1 KB)
Subdocument 1 - SC 13E3/A - SC 13E3/A
Page 1 - UNITED STATES
Page 2 - TABLE OF CONTENTS
Page 3 - INTRODUCTION
Page 4 - N/A
Page 5 - Item 1 Summary Term Sheet
Page 6 - Item 4 Terms of the Transaction
Page 7 - Item 5 Past Contracts, Transactions, Negotiations and Agreements
Page 8 - Item 6 Purposes of the Transaction and Plans or Proposals
Page 9 - Item 7 Purposes, Alternatives, Reasons and Effects
Page 10 - Item 8 Fairness of the Transaction
Page 11 - Item 9 Reports, Opinions, Appraisals and Negotiations
Page 12 - Item 10 Source and Amount of Funds or Other Consideration
Page 13 - Item 12 The Solicitation or Recommendation
Page 14 - Item 14 Persons/Assets, Retained, Employed, Compensated or Used
Page 15 - N/A
Page 16 - SIGNATURES
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Subdocument 2 - EX-99.(A) - (1) - EX-99.(A)-(1)
Page 1 - Exhibit (a)-(1)
Page 2 - N/A
Page 3 - After careful consideration and upon the unanimous recommendation of the Special Committee composed
Page 4 - N/A
Page 5 - ADS HOLDERS WILL NOT HAVE THE RIGHT TO EXERCISE DISSENTER RIGHTS AND RECEIVE PAYMENT OF THE FAIR VAL
Page 6 - SHARES BY THE CLOSE OF BUSINESS IN THE CAYMAN ISLANDS ON THE SHARE RECORD DATE. THEREAFTER, SUCH FOR
Page 7 - IKANG HEALTHCARE GROUP, INC.
Page 8 - N/A
Page 9 - N/A
Page 10 - ADS HOLDERS WILL NOT HAVE THE RIGHT TO EXERCISE DISSENTERS' RIGHTS AND RECEIVE PAYMENT OF THE FAIR V
Page 11 - N/A
Page 12 - PROXY STATEMENT
Page 13 - TABLE OF CONTENTS
Page 14 - SUMMARY TERM SHEET
Page 15 - Yunfeng Fund III, L.P.
Page 16 - Mr. Lee Ligang Zhang
Page 17 - The Merger (Page 119)
Page 18 - Treatment of Company Options (Page 120)
Page 19 - Shareholder Vote Required to Approve the Merger Agreement and Plan of Merger (Page 113)
Page 20 - HOLDERS OF SHARES AND BECOME REGISTERED HOLDERS OF SHARES BY THE CLOSE OF BUSINESS IN THE CAYMAN ISL
Page 21 - agreement and the plan of merger, including the merger and, upon the merger becoming effective, the
Page 22 - Support Agreement (Annex E)
Page 23 - Opinion of the Special Committee's Financial Advisor (Page 78)
Page 24 - Interests of the Company's Executive Officers and Directors in the Merger (Page 98)
Page 25 - Conditions to the Merger (Page 134)
Page 26 - Termination of the Merger Agreement (Page 135)
Page 27 - Termination Fee (Page 137)
Page 28 - Material Cayman Islands Tax Consequences (Page 106)
Page 29 - Market Price of the ADSs (Page 109)
Page 30 - QUESTIONS AND ANSWERS ABOUT THE EXTRAORDINARY GENERAL MEETING AND THE MERGER
Page 31 - Q:How will the Company Options be treated in the merger?
Page 32 - Q:What happens if the merger is not consummated?
Page 33 - Q:After the merger is consummated, how will I receive the merger consideration for my ADSs?
Page 34 - Q:What vote of the Company's shareholders is required to approve the proposal to adjourn the extraor
Page 35 - Q:What constitutes a quorum for the extraordinary general meeting?
Page 36 - Q:How do I vote if I own ADSs?
Page 37 - Q:If my Shares or ADSs are held in a brokerage, bank or other nominee account, will my broker, bank
Page 38 - Q:May I change my vote?
Page 39 - Q:What happens if I sell my Shares or ADSs before the extraordinary general meeting?
Page 40 - Q:What do I need to do now?
Page 41 - SPECIAL FACTORS
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - N/A
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - N/A
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - N/A
Page 78 - Reasons for the Merger and Recommendation of the Special Committee and the Board
Page 79 - N/A
Page 80 - N/A
Page 81 - N/A
Page 82 - N/A
Page 83 - N/A
Page 84 - N/A
Page 85 - Position of the Buyer Group as to the Fairness of the Merger
Page 86 - N/A
Page 87 - N/A
Page 88 - Certain Financial Projections
Page 89 - N/A
Page 90 - N/A
Page 91 - NONE OF THE COMPANY OR ITS AFFILIATES, ADVISORS, OFFICERS, DIRECTORS OR REPRESENTATIVES HAS MADE OR
Page 92 - N/A
Page 93 - N/A
Page 94 - Public Trading Multiples Analysis
Page 95 - N/A
Page 96 - Other Analysis for Information Purpose Only
Page 97 - N/A
Page 98 - Purposes of and Reasons for the Merger
Page 99 - The Company
Page 100 - N/A
Page 101 - Memorandum and Articles of Association of the Surviving Company; Directors and Officers of the Survi
Page 102 - Effect of the Merger on the Company's Net Book Value and Net Earnings
Page 103 - Plans for the Company after the Merger
Page 104 - Alternatives to the Merger
Page 105 - Effects on the Company if the Merger Is Not Completed
Page 106 - Equity Financing
Page 107 - Rollover Equity
Page 108 - Limited Guarantees
Page 109 - N/A
Page 110 - Interim Investors Agreement
Page 111 - Interests of Certain Persons in the Merger
Page 112 - N/A
Page 113 - N/A
Page 114 - N/A
Page 115 - Related Party Transactions
Page 116 - Fees and Expenses
Page 117 - Litigation Relating to the Merger
Page 118 - Material PRC Income Tax Consequences
Page 119 - Material Cayman Islands Tax Consequences
Page 120 - N/A
Page 121 - N/A
Page 122 - MARKET PRICE OF THE COMPANY'S ADSs, DIVIDENDS AND OTHER MATTERS
Page 123 - N/A
Page 124 - THE EXTRAORDINARY GENERAL MEETING
Page 125 - The Board's Recommendation
Page 126 - Vote Required
Page 127 - ADSs
Page 128 - Proxy Holders for Registered Shareholders
Page 129 - Revocability of Proxies
Page 130 - Rights of Shareholders Who Object to the Merger
Page 131 - Whom to Call for Assistance
Page 132 - THE MERGER AGREEMENT AND PLAN OF MERGER
Page 133 - Merger Consideration
Page 134 - Representations and Warranties
Page 135 - N/A
Page 136 - N/A
Page 137 - Conduct of Business Prior to Closing
Page 138 - N/A
Page 139 - Conduct of Business by Parent and Merger Sub Pending the Merger
Page 140 - Acquisition Proposals
Page 141 - N/A
Page 142 - No Change of Recommendation
Page 143 - Financing
Page 144 - Directors' and Officers' Indemnification and Insurance
Page 145 - Support Agreement
Page 146 - Other Covenants
Page 147 - Conditions to the Merger
Page 148 - Termination of the Merger Agreement
Page 149 - N/A
Page 150 - Termination Fee
Page 151 - Amendment Waiver
Page 152 - PROVISIONS FOR UNAFFILIATED SHAREHOLDERS
Page 153 - DISSENTERS' RIGHTS
Page 154 - N/A
Page 155 - FINANCIAL INFORMATION
Page 156 - Ratio of Earnings to Fixed Charges
Page 157 - TRANSACTIONS IN THE SHARES AND ADSS
Page 158 - Share Pledge to AVIC Trust Co., Ltd.
Page 159 - Transactions in Prior 60 Days
Page 160 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT OF THE COMPANY
Page 161 - N/A
Page 162 - N/A
Page 163 - FUTURE SHAREHOLDER PROPOSALS
Page 164 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 165 - N/A
Page 166 - WHERE YOU CAN FIND MORE INFORMATION
Page 167 - ANNEX A: AGREEMENT AND PLAN OF MERGER AND AMENDMENT NO. 1 TO THE
Page 168 - TABLE OF CONTENTS
Page 169 - N/A
Page 170 - N/A
Page 171 - N/A
Page 172 - N/A
Page 173 - ARTICLE I
Page 174 - ARTICLE II
Page 175 - N/A
Page 176 - N/A
Page 177 - N/A
Page 178 - N/A
Page 179 - ARTICLE III
Page 180 - N/A
Page 181 - N/A
Page 182 - ), Radiation Safety Licenses ( ) and Permits for Radiological Diagnosis and Treatment ( ), except fo
Page 183 - N/A
Page 184 - N/A
Page 185 - N/A
Page 186 - N/A
Page 187 - N/A
Page 188 - N/A
Page 189 - N/A
Page 190 - N/A
Page 191 - N/A
Page 192 - ARTICLE IV
Page 193 - N/A
Page 194 - N/A
Page 195 - N/A
Page 196 - ARTICLE V
Page 197 - N/A
Page 198 - N/A
Page 199 - N/A
Page 200 - ARTICLE VI
Page 201 - N/A
Page 202 - N/A
Page 203 - N/A
Page 204 - N/A
Page 205 - N/A
Page 206 - N/A
Page 207 - N/A
Page 208 - N/A
Page 209 - N/A
Page 210 - N/A
Page 211 - N/A
Page 212 - N/A
Page 213 - ) to, use commercially reasonable efforts to facilitate and assist in discussions with the relevant
Page 214 - N/A
Page 215 - ARTICLE VIII
Page 216 - N/A
Page 217 - N/A
Page 218 - N/A
Page 219 - ARTICLE IX
Page 220 - N/A
Page 221 - N/A
Page 222 - ), Hangzhou iKang Guobin Clinic Co., Ltd. ( ), Shanghai Yuanhua Information Technology Co., Ltd. ( )
Page 223 - N/A
Page 224 - N/A
Page 225 - N/A
Page 226 - N/A
Page 227 - N/A
Page 228 - N/A
Page 229 - N/A
Page 230 - N/A
Page 231 - N/A
Page 232 - APPENDIX I
Page 233 - Execution Version
Page 234 - 3. Miscellaneous
Page 235 - N/A
Page 236 - N/A
Page 237 - N/A
Page 238 - N/A
Page 239 - APPENDIX I
Page 240 - ANNEX B:
Page 241 - EFFECTIVE DATE
Page 242 - MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION
Page 243 - N/A
Page 244 - ANNEX C: OPINION OF J.P. MORGAN SECURITIES (ASIA PACIFIC) LIMITED AS FINANCIAL
Page 245 - N/A
Page 246 - N/A
Page 247 - ANNEX D: CAYMAN COMPANIES LAW CAP. 22 (LAW 3 OF 1961, AS CONSOLIDATED AND REVISED) SECTION 238
Page 248 - N/A
Page 249 - ANNEX E: SUPPORT AGREEMENT
Page 250 - ARTICLE I
Page 251 - Section 1.3 Restrictions on Transfers. Except (i) as provided for in Article II below, (ii) pursuant
Page 252 - ARTICLE II
Page 253 - Section 2.3 Rollover Closing. Subject to the satisfaction in full (or waiver, if permissible) of all
Page 254 - Section 3.2 Covenants. Each Shareholder hereby:
Page 255 - ARTICLE IV
Page 256 - ARTICLE V
Page 257 - ARTICLE VI
Page 258 - Section 6.8 Governing Law. This Agreement shall be governed by, and construed in accordance with, th
Page 259 - Section 6.13 Counterparts. This Agreement may be executed in two or more consecutive counterparts (i
Page 260 - N/A
Page 261 - N/A
Page 262 - N/A
Page 263 - N/A
Page 264 - N/A
Page 265 - N/A
Page 266 - Execution Version
Page 267 - 3. Miscellaneous
Page 268 - N/A
Page 269 - N/A
Page 270 - N/A
Page 271 - N/A
Page 272 - N/A
Page 273 - N/A
Page 274 - ANNEX F: DIRECTORS AND EXECUTIVE OFFICERS OF EACH FILING PERSON
Page 275 - N/A
Page 276 - 2. Directors and Executive Officers of Parent
Page 277 - 3. Directors and Executive Officers of Merger Sub
Page 278 - 5. Directors and Executive Officers of YF Fund III and YF Fund III Parallel
Page 279 - N/A
Page 280 - N/A
Page 281 - N/A
Page 282 - N/A
Page 283 - N/A
Page 284 - N/A
Page 285 - N/A
Page 286 - N/A
Page 287 - 7. Directors and Executive Officers of Boyu Fund III
Page 288 - 8. Directors and Executive Officers of Time Intelligent
Page 289 - 10. Directors and Executive Officers of Top Fortune
Page 290 - ANNEX G: FORM OF PROXY CARD
Page 291 - N/A
Page 292 - To be valid, this form of proxy, together with the power of attorney or other authority (if any) und
Page 293 - N/A
Page 294 - SPECIAL RESOLUTIONS
Page 295 - PLEASE MARK, DATE AND SIGN ON REVERSE SIDE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.


Copyright © 2004- iKang Healthcare Group, Inc. All Rights Reserved.
经营许可证编号:京ICP证041625号 京ICP备07503198号-1 京公网安备:110105000860